APNHF (Aspen Pharmacare Holdings) Cyclically Adjusted PB Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

APNHF Aspen Pharmacare Holdings Ltd APNHF
63 GF Score
Price $8.90
GF Value $9.34
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Aspen Pharmacare Holdings Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Aspen Pharmacare Holdings  (OTCPK:APNHF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Aspen Pharmacare Holdings Cyclically Adjusted PB Ratio Related Terms


Aspen Pharmacare Holdings Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Aspen Pharmacare Holdings's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspen Pharmacare Holdings Cyclically Adjusted PB Ratio Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.89 0.92 1.16 0.66 0.75

Aspen Pharmacare Holdings Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.16 1.15 0.66 0.56 0.75

APNHF vs ZTS, UTHR, VTRS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aspen Pharmacare Holdings Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Aspen Pharmacare Holdings's Cyclically Adjusted PB Ratio falls into.


APNHF
63GF Score
Aspen Pharmacare Holdings Ltd APNHF
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspen Pharmacare Holdings Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Aspen Pharmacare Holdings's Cyclically Adjusted Book per Share for the fiscal year that ended in Jun26 is calculated as:

For example, Aspen Pharmacare Holdings's adjusted Book Value per Share data for the fiscal year that ended in Jun26 was:

Adj_Book=Book Value per Share/CPI of Jun26 (Change)*Current CPI (Jun26)
=11.042/169.0200*169.0200
=11.042

Current CPI (Jun26) = 169.0200.

Aspen Pharmacare Holdings Annual Data

Book Value per Share CPI Adj_Book
201706 7.213 112.054 10.880
201806 7.899 116.959 11.415
201906 8.435 122.191 11.668
202006 8.745 124.807 11.843
202106 10.098 131.113 13.018
202206 9.732 140.835 11.680
202306 10.276 148.802 11.672
202406 10.462 156.269 11.316
202506 10.758 160.985 11.295
202606 11.042 169.020 11.042

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Aspen Pharmacare Holdings (APNHF) Overvalued in 2026?

Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued. The current stock price of $8.90 is trading 4.8% below its estimated GF Value™ of $9.34. GuruFocus considers Aspen Pharmacare Holdings to be Fairly Valued.

Key valuation signals for APNHF:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: $9.34 vs. price of $8.90 (4.8% below fair value)
  • GF Score™: 63/100 with 10 warning signs

No single metric tells the full story. See the APNHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aspen Pharmacare Holdings Business Description

Address Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
63GF Score

Get the complete analysis for APNHF

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$8.90
Price
$9.34
GF Value